SCHEMBL4367288

SCHEMBL4367288

O=C(N[C@@H](Cc1ccccc1)C(=O)N[C@H](CO)Cc1ccccc1)c1ccc(O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 6/20 0.58
MAPK1 P28482 2/20 0.57
ROCK2 O75116 1/20 0.57
RPS6KA5 O75582 1/20 0.57
RPS6KA4 O75676 1/20 0.57
PRKACA P17612 1/20 0.57
GSK3A P49840 1/20 0.57
GSK3B P49841 1/20 0.57
IRAK1 P51617 1/20 0.57
PRKX P51817 1/20 0.57
ROCK1 Q13464 1/20 0.57
PRKG1 Q13976 1/20 0.57
PKN2 Q16513 1/20 0.57
CLK4 Q9HAZ1 1/20 0.57
SGK2 Q9HBY8 1/20 0.57
CYP3A4 P08684 1/20 0.56
CTSS P25774 3/20 0.53
CTSK P43235 3/20 0.53
CTSB P07858 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4364556 0.96 CTSL (0.63) CTSLMAPK1ROCK2RPS6KA5RPS6KA4
SCHEMBL4365199 0.93 NPC1 (0.60) CTSLMAPK1ROCK2RPS6KA5RPS6KA4
SCHEMBL4357884 0.93 CTSL (0.55) CTSLMAPK1ROCK2RPS6KA5RPS6KA4
SCHEMBL4360662 0.93 CTSL (0.57) CTSLMAPK1ROCK2RPS6KA5RPS6KA4
SCHEMBL4372161 0.92 CTSL (0.61) CTSLMAPK1ROCK2RPS6KA5RPS6KA4
SCHEMBL4365220 0.89 CTSL (0.53) CTSLMAPK1ROCK2RPS6KA5RPS6KA4
SCHEMBL24368209 0.89 NPC1 (0.67) CTSLMAPK1ROCK2RPS6KA5RPS6KA4
SCHEMBL4360827 0.89 MAPK1 (0.58) CTSLMAPK1ROCK2RPS6KA5RPS6KA4
SCHEMBL4364557 0.89 CTSL (0.58) CTSLMAPK1ROCK2RPS6KA5RPS6KA4
SCHEMBL28523278 0.89 NPC1 (0.67) CTSLMAPK1ROCK2RPS6KA5RPS6KA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247470-A1 PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF The Key Lab. Of Chemistry for Natural Products of Guizhou Province and Chinese Acad. of Sciences (CN) 2009-10-01 US claimed
US-9023809-B2 Phenylalanine dipeptide derivatives, compositions and use thereof THE KEY LABORATORY OF CHEMISTRY FOR NATURAL PRODUCTS OF GUIZHOU PROVINCE AND CHINESE ACADEMY OF SCIENCES (CN) 2015-05-05 US disclosed
US-20090247470-A1 PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF The Key Lab. Of Chemistry for Natural Products of Guizhou Province and Chinese Acad. of Sciences (CN) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247470-A1 PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF DNPEP, PEPD, VIP CTSL 591/4885MAPK1 2260/4885ROCK2 4037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.